Adhesion molecules and differentiation syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia

Autor(es):Mostrar menos -

De Santis, Gil Cunha ; Tamarozzi, Mirela de Barros ; Sousa, Romualdo Barroso ; Moreno, Susana Elisa ; Secco, Daniela ; Garcia, Aglair Bergamo ; Gouveia Lima, Ana Silvia ; Faccioli, Lucia Helena ; Falcao, Roberto Passetto ; Cunha, Fernando Queiros ; Rego, Eduardo Magalhaes

• Tipo de documento: Artigo Científico
• Fonte: Haematologica; v. 92, n. 12, p. 8-pg., 2007-11-30.

Resumo

Background and Objectives Differentiation Syndrome (DS) is a treatment complication which can occur in patients treated with acute promyelocytic leukemia (APL) with all trans-retinoic acid (ATRA) or As2O3, and is characterized by enhanced leukocyte transmigration. As2O3, Phenylbutyrate (PB) and G-CSF are known to potentiate ATRA effects. Our aim was to analyze the changes in expression and function of adhesion molecules induced by ATRA, As2O3, G-CSF and PB, and their association. Design and Methods APL blasts and NB4 cells were treated with ATRA, As2O3, PB, G-CSF or their association and the expression of adhesion molecules was determined by flow cytometry. Cell adhesion was evaluated in vitro using Matrigel and for the in vivo analysis, Babe mice were injected with NB4 cells pre-treated with ATRA, As2O3, ATRA+G-CSF or ATRA+As2O3. In addition, CD54 and CD18 knock-out mice were injected with NB4 cells and concomitantly treated with ATRA. In both models, the MPO activity in the lungs was determined 6 hours after the injection of the cells. Results In NB4 and APL blasts, ATRA and As2O3 increased CD54 expression, but no synergism was detected. CD11b and CD18 were also up-regulated by ATRA in primary cells. PB and G-CSF had no effect, but the latter potentiated ATRA-induced CD18 up-regulation. These changes were accompanied by increased adhesion to Matrigel and to lung microvasculature, and reversed by anti-CD54, anti-CD18 antibodies. In CD54 and CD18 knock-out mice the ATRA effect was canceled. Interpretation and Conclusions The use of As2O3, PB and G CSF in association with ATRA should not aggravate DS in APL. (AU)

• Processo FAPESP: 98/14247-6 - Center for Research on Cell-Based Therapy
• Beneficiário: Marco Antonio Zago
• Modalidade de apoio: Auxílio à Pesquisa - Centros de Pesquisa, Inovação e Difusão - CEPIDs